Sarah Boyce - Insider Trading & Ownership

Entity
Individual
Location
C/O Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA
Summary
The estimated net worth of Sarah Boyce is at least $13.6M dollars as of September 23, 2024. Sarah Boyce is the President and CEO, Director of Avidity Biosciences, Inc. and owns shares of Avidity Biosciences, Inc. (RNA) stock worth about $13.1M. Sarah Boyce is the Director of OmniAb, Inc. and owns shares of OmniAb, Inc. (OABI) stock worth about $302K. Sarah Boyce is the Former Director of LIGAND PHARMACEUTICALS INC and owns shares of LIGAND PHARMACEUTICALS INC (LGND) stock worth about $209K. Sarah Boyce is the Director of Berkeley Lights, Inc. and owns shares of Bruker Cellular Analysis, Inc. stock worth about $770.
All Insider Reports
All Insider Reports

Ownership of Sarah Boyce

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNA Avidity Biosciences, Inc. President and CEO, Director $13.1M -$23M -63.8% Sep 19, 2024
OABI, OABIW OmniAb, Inc. Director $302K Jun 18, 2024
LGND, LGNDZ LIGAND PHARMACEUTICALS INC Former Director $209K Nov 1, 2022
CELL Bruker Cellular Analysis, Inc. Director $770 May 14, 2021
CTNM Contineum Therapeutics, Inc. Director Jun 24, 2024

Insider Transactions Reported by Sarah Boyce:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.